Highlights

• Co-Director, Clinical Trials, Gastrointestinal Oncology Disease Center at Dana-Farber Cancer Institute

• Co-Director, Pheo Para Alliance Clinical Center of Excellence Designated for Pheochromocytoma and Paraganglioma at Dana-Farber Cancer Institute and Mass General Brigham Hospital

• Active member and past Chair of the Scientific Review Research Committee of North American Neuroendocrine Tumor Society

• Co-Author of the Systemic Therapy for Well-differentiated Gastroenteropancreatic Neuroendocrine Neoplasms: ASCO 2023 Guidelines and NANETS 2021 Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma Guidelines

• Clinical Investigator at the Hale Family Center for Pancreatic Cancer Research

Experience

Kimberly Perez, MD is a Medical Oncologist and member of the Dana-Farber Cancer Institute/Harvard Cancer Center Gastrointestinal Oncology and Cancer Genetics and Prevention disease centers. She is a Senior Physician in Medical Oncology at Dana-Farber Cancer Institute, co-Director of the DFCI Gastrointestinal Clinical Trials program, an Associate Physician in Medical Oncology at Brigham and Women’s Hospital, and an Assistant Professor of Medicine at Harvard Medical School. 

Dr. Perez is a physician-scientist who conducts clinical research of novel therapies and provides care for patients diagnosed with gastrointestinal cancers and inherited cancer syndromes. She was designated a Hale Family Center for Pancreatic Cancer Research Clinical Investigator and has developed and led bench-to-clinic, multi-institutional clinical trials for patients with pancreatic adenocarcinoma. She's also led multi-institutional clinical trials, translational efforts, and national therapeutic guideline efforts within the Neuroendocrine and Carcinoid program. 

Education

Dr. Perez received her undergraduate training at Georgetown University and her medical doctorate from George Washington University, both in Washington DC. She completed her residency and fellowship at Rhode Island Hospital, after which she joined the Warren Alpert School of Medicine at Brown University's medical faculty and served at the Comprehensive Cancer Center at Rhode Island Hospital as a Gastrointestinal Oncologist. She joined the Dana-Farber Cancer Institute faculty in 2015 as a medical oncology physician-scientist.